<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04797572</url>
  </required_header>
  <id_info>
    <org_study_id>CALIBRATE TRIAL01</org_study_id>
    <secondary_id>2020-14DEC/619</secondary_id>
    <nct_id>NCT04797572</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)</brief_title>
  <acronym>CALIBRATE</acronym>
  <official_title>CALIBRATE TRIAL: a Prospective, Single Arm Investigational Clinical Trial Evaluating Safety and Performance of the Free Margin Cusp Sizer During Aortic Valve Repair Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate safety and performance of the Free Margin Cusp&#xD;
      sizer. The device will be used during aortic valve repair and sparing procedures as a caliper&#xD;
      to measure the aortic valve free margin length at different stages of the procedure. The&#xD;
      patient will be followed for one year clinically (at 1, 2, 6 and 12 months) and by&#xD;
      echocardiography (at 6 and 12 months) to assess aortic valve function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative aortic valve (AV) damage</measure>
    <time_frame>30 days</time_frame>
    <description>Aortic valve damage caused by the cusp sizer (cusp tear or perforation), rate of conversion from AV repair to AV replacement due to the use of the cusp sizer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Patient Survival status at 30 days after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major adverse cardiac and cerebrovascular events (MACCE)</measure>
    <time_frame>one year</time_frame>
    <description>Mortality, stroke or transient ischemic attack, major bleeding, cardiac reintervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aortic valve function</measure>
    <time_frame>One year</time_frame>
    <description>Aortic valve regurgitation and transvalvular gradient by transthoracic echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pre-repair free margin length</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Length of the 3 leaflets free margin before aortic valve repair</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-repair free margin length</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Length of the 3 leaflets free margin after aortic valve repair</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aortic Valve Regurgitation</condition>
  <condition>Aortic Root Aneurysm</condition>
  <arm_group>
    <arm_group_label>Treated group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients in whom the free margin cusp sizer will be used to measure the free margin of the three leaflets of the aortic valve during aortic valve repair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Free Margin Cusp Sizer</intervention_name>
    <description>The free margin cusp sizer will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length.</description>
    <arm_group_label>Treated group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with Tricuspid Aortic Valve (TAV) operated electively for aortic valve&#xD;
             regurgitation and or ascending aorta dilatation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute aortic dissection;&#xD;
&#xD;
          -  Diffuse aortic valve calcification;&#xD;
&#xD;
          -  AV endocarditis;&#xD;
&#xD;
          -  Bicuspid, unicuspid or quadricuspid aortic valves;&#xD;
&#xD;
          -  Patients under the age of 18 years;&#xD;
&#xD;
          -  Patients above the age of 80 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent de kerchove</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent de Kerchove, MD, PhD</last_name>
    <phone>+32 2 764 41 51</phone>
    <email>laurent.dekerchove@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corinne Coulon</last_name>
    <phone>+32 2 764 6108</phone>
    <email>corinne.coulon@uclouvain.be</email>
  </overall_contact_backup>
  <reference>
    <citation>De Kerchove L, Momeni M, Aphram G, Watremez C, Bollen X, Jashari R, Boodhwani M, Astarci P, Noirhomme P, El Khoury G. Free margin length and coaptation surface area in normal tricuspid aortic valve: an anatomical study. Eur J Cardiothorac Surg. 2018 May 1;53(5):1040-1048. doi: 10.1093/ejcts/ezx456.</citation>
    <PMID>29253123</PMID>
  </reference>
  <reference>
    <citation>Tamer S, Mastrobuoni S, van Dyck M, Navarra E, Bollen X, Poncelet A, Noirhomme P, Astarci P, El Khoury G, de Kerchove L. Free margin length and geometric height in aortic root dilatation and leaflet prolapse: implications for aortic valve repair surgery. Eur J Cardiothorac Surg. 2020 Jan 1;57(1):124-132. doi: 10.1093/ejcts/ezz132. Erratum in: Eur J Cardiothorac Surg. 2020 Jan 1;57(1):206.</citation>
    <PMID>31089691</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic valve repair</keyword>
  <keyword>Valve sparing surgery</keyword>
  <keyword>Trileaflet aortic valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

